Source: Medical Buyer

Wexford Capital: R3 Vascular completes Series A financing

R3 Vascular Inc. announced the closing of its Series A financing round, including new equity investments of $15 million and the conversion of $2.8 million of convertible notes. The round was...Read More

Read full article »
Wexford Capital's Competitors | Wexford Capital's News | Wexford Capital's Financials
Stay up-to-date with the latest news on Wexford Capital
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Joseph M. Jacobs's photo - President of Wexford Capital

President

Joseph M. Jacobs

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Wexford Capital